GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Daiken Medical Co 7775.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

412

0.00%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥10.29bn

FY2017FY2026

Net income

¥922.6m

FY2017FY2026

Free cash flow

¥240.2m

FY2017FY2026

Shareholders' equity

¥7.78bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥10.29bn¥9.95bn¥9.75bn¥9.14bn¥8.54bn¥7.86bn¥8.52bn¥8.41bn¥8.59bn¥8.40bn
Gross profit¥3.95bn¥4.10bn¥3.98bn¥3.53bn¥3.68bn¥3.36bn¥3.73bn¥3.94bn¥4.23bn¥4.41bn
Research and development——¥249.0m¥316.0m¥382.0m¥448.0m¥488.0m¥512.0m¥532.9m¥479.8m
Operating income¥1.28bn¥1.51bn¥1.44bn¥1.05bn¥1.16bn¥948.6m¥1.19bn¥1.25bn¥1.51bn¥1.71bn
Net income¥922.6m¥1.10bn¥988.6m¥712.1m¥831.1m¥675.2m¥859.5m¥851.6m¥1.01bn¥1.25bn
Diluted earnings per share32.1238.2134.4124.7928.9323.5029.9229.6435.2341.59

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥11.37bn¥11.18bn¥11.01bn¥11.01bn¥10.92bn¥10.75bn¥11.00bn¥10.97bn¥11.14bn¥11.01bn
Cash and short-term investments¥2.78bn¥3.00bn¥2.74bn¥2.52bn¥2.52bn¥2.17bn¥2.37bn¥2.22bn¥2.37bn¥2.32bn
Total liabilities¥3.59bn¥3.67bn¥3.98bn¥4.42bn¥4.47bn¥4.57bn¥4.92bn¥5.20bn¥4.44bn¥3.73bn
Debt¥2.25bn¥2.03bn¥2.14bn¥2.73bn¥2.93bn¥2.97bn¥2.91bn¥3.44bn¥2.46bn¥1.43bn
Shareholders' equity¥7.78bn¥7.52bn¥7.02bn¥6.60bn¥6.45bn¥6.18bn¥6.08bn¥5.77bn¥6.69bn¥7.28bn
Shares outstanding29m29m29m29m29m29m29m29m29m30m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥567.7m¥1.12bn¥1.56bn¥989.2m¥1.13bn¥609.2m¥1.44bn¥880.9m¥1.26bn¥1.35bn
Capital spending−¥327.5m−¥166.5m−¥168.8m−¥199.0m−¥203.2m−¥312.0m−¥169.2m−¥207.2m−¥637.6m−¥612.1m
Free cash flow¥240.2m¥954.4m¥1.39bn¥790.1m¥930.4m¥297.1m¥1.27bn¥673.8m¥617.5m¥738.2m
Dividends paid−¥660.2m−¥612.8m−¥573.0m−¥565.3m−¥574.3m−¥574.9m−¥546.1m−¥773.3m−¥809.4m−¥480.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥2.44bn¥2.41bn¥2.82bn¥2.56bn¥2.50bn¥2.29bn¥2.75bn¥2.52bn
Gross profit¥861.7m¥882.0m¥1.10bn¥1.01bn¥955.5m¥874.3m¥1.14bn¥1.06bn
Operating income¥214.6m¥162.0m¥439.6m¥394.2m¥281.9m¥196.1m¥480.0m¥439.6m
Net income¥167.4m¥81.9m¥328.9m¥296.4m¥215.5m¥140.3m¥349.3m¥319.3m
Diluted earnings per share5.832.8511.4510.327.504.8812.1611.11
Total assets¥11.08bn¥11.37bn¥11.11bn¥10.83bn¥10.94bn¥11.18bn¥11.40bn¥11.39bn
Cash and short-term investments¥2.44bn¥2.78bn¥2.38bn¥2.31bn¥2.50bn¥3.00bn¥2.97bn¥3.16bn
Debt¥1.36bn¥2.24bn¥1.31bn¥1.67bn¥1.07bn¥2.02bn¥1.41bn¥2.46bn
Shareholders' equity¥7.63bn¥7.78bn¥7.70bn¥7.63bn¥7.33bn¥7.52bn¥7.38bn¥7.29bn

Financial ratios

Data as of 1 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin38.4%41.2%40.8%38.6%43.1%42.7%——
Operating margin12.4%15.2%14.8%11.5%13.5%12.1%——
Net margin9.0%11.0%10.1%7.8%9.7%8.6%——
Return on equity11.9%14.6%14.1%10.8%12.9%10.9%——
Return on assets8.1%9.8%9.0%6.5%7.6%6.3%——
Free cash flow yield7.4%10.7%14.3%9.8%11.1%7.6%——
Revenue growth3.4%2.1%6.7%7.0%8.6%-7.8%——
Earnings growth-15.9%11.0%38.8%-14.3%23.1%-21.4%——
Current ratio2.58x2.47x2.02x1.97x2.09x1.87x——
Debt to equity0.29x0.27x0.30x0.41x0.45x0.47x——
Equity ratio68.4%67.2%63.8%59.9%59.0%57.5%——
Interest coverage103.55x161.48x298.99x265.94x309.09x249.16x——
R&D as a share of sales——2.6%3.5%4.5%5.7%5.7%6.1%
Buybacks as a share of market value0.0%0.0%0.0%0.0%0.0%0.0%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue4.0%5.5%2.2%
Operating income6.6%6.1%-2.8%
Net income9.0%6.4%-2.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin39.8%39.8%40.7%44.2%
Operating margin13.8%13.5%13.3%15.1%
Net margin10.0%9.5%9.4%10.6%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings12.911.715.220.715.523.817.922.517.318.6
Price to sales1.21.31.51.61.52.01.82.32.02.8

Dividends and splits

Per share, in the currency the company pays

Paid for 17 years. Last went ex-dividend on 30 Mar 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year34.0021.0020.0020.0020.0020.0019.0022.00
  • 2-for-1 split · 13 Nov 2014
  • 2-for-1 split · 26 Jun 2013
  • 2-for-1 split · 25 Sept 2009

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.